A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples